Organization
Baudax Bio
6 clinical trials
Clinical trial
A Phase 3b, Randomized, Double-Blind, Placebo-Control, Multicenter, Evaluation of the Safety and Efficacy of N1539 Administered Preoperatively in Open Unilateral Total Knee ArthroplastyStatus: Completed, Estimated PCD: 2019-05-21
Clinical trial
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Evaluation of the Efficacy and Safety of DEX-IN Following Painful Outpatient ProceduresStatus: Completed, Estimated PCD: 2018-01-18
Clinical trial
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Evaluation of the Safety of N1539 Following Major SurgeryStatus: Completed, Estimated PCD: 2017-03-01
Clinical trial
A Phase 4, Multicenter, Open-Label Study to Evaluate the Safety and Pharmacokinetics of N1539 in Children 2 to <17 Years of Age Following SurgeryStatus: Terminated, Estimated PCD: 2022-07-07
Clinical trial
A Phase 2, Randomized, Double-Blind, Active-Controlled, Evaluation of Intubation Conditions Following BX1000 or Rocuronium in Subjects Undergoing SurgeryStatus: Completed, Estimated PCD: 2023-04-10
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Evaluation of the Safety and Efficacy of Preoperative N1539 In Colorectal SurgeryStatus: Completed, Estimated PCD: 2018-09-26